AdminMed

AdminMed has presented Advanced microneedle products at the recent prestigious 2019 Drug Delivery West Conference in San Francisco, CA. AdminMed, a leading microneedle array company, is producing and selling several hollow metal microneedle array devices in the full spectrum of various sizes. AdminPen injection devices allow intradermal injections over 1 cm2 skin area for more effective and painless delivery of immunotherapies and all other injectable formulations Including therapeutic peptides, proteins, antibodies, and nucleotides. AdminStamp devices perforate skin for improving the absorption of topical formulations. AdminPatch microneedle patches enable delivering any APIs transdermally using conventional drug-in-adhesive formulations: https://theconferenceforum.org//drug-deliver/2019-agenda/

AdminPen devices manufactured and sold by AdminMed, a leading microneedle array products company, are featured in the recently published comprehensive review of microfabrication technologies for biomedical applications: Koch, Brendan; Rubino, Ilaria; Quan, Fu-Shi; Yoo, Bongyoung; Choi, Hyo-Jick. 2016. "Microfabrication for Drug Delivery." Materials 9, no. 8: 646. This review is devoted to discussing the application of microfabrication technologies to target challenges e...ncountered in life processes by the development of drug delivery systems. Recently, microfabrication has been largely applied to solve health and pharmaceutical science issues. In particular, fabrication methods along with compatible materials have been successfully designed to produce multifunctional, highly effective drug delivery systems. Microfabrication offers unique tools that can tackle problems in this field, such as ease of mass production with high quality control and low cost, complexity of architecture design and a broad range of materials. Microfabrication will continue to offer new, alternative solutions for the development of smart, advanced drug delivery systems. View Full-Text PDF using the following link: http://www.adminmed.com//2016-Microfabrication-for-Drug-De About AdminMed AdminMed is a medical device company producing metal microneedle array devices ("AdminPen") allowing more effective and painless injection of cancer immuno-therapies, vaccines, pharmaceutical drugs, and cosmetics. The patented AdminPen devices use hollow microneedle channels to deliver a medicine (liquid or particulate) uniformly into 1 cm skin area. The AdminPen devices have been used to improve the efficacy of a cancer nanoparticle immunotherapies several times (4-16 times!) in comparison to same immunotherapy injected using a traditional needle and syringe. Please also review the complete collection of 34 scientific papers published by us and our academic clients summarizing results of successful in-vivo and in-vitro studies with our microneedle array products: http://www.adminmed.com/publications

AdminMed is selected to present at 2018 Drug Delivery Design & Partnering Meeting in San Francisco, CA. Dr. Vadim Yuzhakov presents "AdminMed hollow metal microneedle array devices for painless intradermal injections over the large skin area and more effective transdermal drug delivery" on May 21: http://theconferenceforum.org/confere/drug-delivery-west//

Very useful event for start-ups - we look forward to seeing you there: https://www.facebook.com/events/737950286358747/

AdminPen devices manufactured and sold by AdminMed, a leading microneedle array products company, are featured in the recently published comprehensive review of microfabrication technologies for biomedical applications: Koch, Brendan; Rubino, Ilaria; Quan, Fu-Shi; Yoo, Bongyoung; Choi, Hyo-Jick. 2016. "Microfabrication for Drug Delivery." Materials 9, no. 8: 646. This review is devoted to discussing the application of microfabrication technologies to target challenges e...ncountered in life processes by the development of drug delivery systems. Recently, microfabrication has been largely applied to solve health and pharmaceutical science issues. In particular, fabrication methods along with compatible materials have been successfully designed to produce multifunctional, highly effective drug delivery systems. Microfabrication offers unique tools that can tackle problems in this field, such as ease of mass production with high quality control and low cost, complexity of architecture design and a broad range of materials. Microfabrication will continue to offer new, alternative solutions for the development of smart, advanced drug delivery systems. View Full-Text PDF using the following link: http://www.adminmed.com//2016-Microfabrication-for-Drug-De About AdminMed AdminMed is a medical device company producing metal microneedle array devices ("AdminPen") allowing more effective and painless injection of cancer immuno-therapies, vaccines, pharmaceutical drugs, and cosmetics. The patented AdminPen devices use hollow microneedle channels to deliver a medicine (liquid or particulate) uniformly into 1 cm skin area. The AdminPen devices have been used to improve the efficacy of a cancer nanoparticle immunotherapies several times (4-16 times!) in comparison to same immunotherapy injected using a traditional needle and syringe. Please also review the complete collection of 34 scientific papers published by us and our academic clients summarizing results of successful in-vivo and in-vitro studies with our microneedle array products: http://www.adminmed.com/publications

AdminMed was selected to present at the upcoming annual Emerging Medical Technologies (EMT) Summit 2016, being held on November 9-11, 2016 at the Sofitel Hotel in the heart of medical technology development and investment in California's Silicon Valley near San Francisco, CA, USA. At this conference, AdminMed will meet with pharmaceutical and medical-device companies as well as with venture capital investors to discuss its microneedle array device AdminPen for more effective delivery of cancer immunotherapies and vaccines. The 2016 EMT Summit audience will include top medical device VCs and business development executives, along with management teams from many of the most promising start-ups in the device space: https://www.innovationinmedtech.com/emerging-medical-techn/

AdminMed has strengthened its patent portfolio with receiving new Granted European Patent AdminMed, a leading microneedle array products company, has recently strengthened its position in the European market by adding a very broad granted European patent to its existing intellectual property portfolio protecting its core microneedle array technology. The European Patent Office has granted Patent No. 1973479, which protects current and next generation AdminMed's microneedle a...rray products throughout all Europe including Austria, Belgium, Bulgaria, Switzerland, Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Iceland, Italy, Liechtenstein, Lithuania, Luxembourg, Latvia, Monaco, Netherlands, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia, and Turkey. The granted European 1973479 patent claims protect AdminMed's microneedle array products, their methods of manufacturing and use, and the microneedle array applicators across all of their clinical indications. http://www.adminmed.com/files/web/patents/EP1973479-NBS.pdf About AdminMed AdminMed is a medical device company producing metal microneedle array devices ("AdminPen") allowing more effective and painless injection of cancer immuno-therapies, vaccines, pharmaceutical drugs, and cosmetics. The patented AdminPen devices use hollow microneedle channels to deliver a medicine (liquid or particulate) uniformly into 1 cm skin area. The AdminPen devices have been used to improve the efficacy of a cancer nanoparticle immunotherapies several times (4-16 times!) in comparison to same immunotherapy injected using a traditional needle and syringe.

https://youtu.be/Qd3DhyKEFBA Our into video for StartX

AdminMed / nanoBioSciences LLC is Recognized for Its Leadership in the Development of the Microneedle Array Technology SUNNYVALE, CA, September, 24th, 2012 Scrip 100 selects nanoBioSciences LLC as one of the leading companies in the development of microneedle technologies. Scrip 100 is an annual guide published by the SCRIP Intelligence which is the leading source of news and strategic analysis for the global pharmaceutical industry. Drug delivery innovations bring complia...Continue reading

nanoBioSciences LLC (DBA AdminMed) is included on the list of the major players in the microneedle technology sector. A leading international market research firm "Research and Markets has announced the addition of the "Microneedle Drug Delivery: Technology, Devices, Players, Markets & Prospects" report to their offering. Our company included on the list of the major players in this technology sector.